China Meheco Group Co., Ltd. (SHA:600056)

Market Cap	15.84B
Revenue (ttm)	33.64B
Net Income (ttm)	556.25M
Shares Out	1.50B
EPS (ttm)	0.37
PE Ratio	28.48
Forward PE	n/a
Dividend	0.11 (1.01%)
Ex-Dividend Date	Sep 27, 2024

Volume	7,220,060
Average Volume	10,418,190
Open	10.59
Previous Close	10.59
Day's Range	10.54 - 10.62
52-Week Range	9.47 - 13.88
Beta	0.23
RSI	59.47
Earnings Date	Aug 26, 2025

About China Meheco Group

China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1984
• Employees: 8,368
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600056

Financial Performance

In 2024, China Meheco Group's revenue was 34.15 billion, a decrease of -12.04% compared to the previous year's 38.82 billion. Earnings were 535.47 million, a decrease of -48.91%.